The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for linerixibat for the treatment of cholestatic pruritus in patients with primary biliary cholangitis ...

Just in time for allergy season, a recent FDA warning describes a new side effect for those who take Zyrtec or Xyzal ...

London: GSK plc has announced the New Drug Application (NDA) for linerixibat, an investigational targeted inhibitor of the ...

(Alliance News) - GSK PLC on Monday announced the US Food & Drug Administration has accepted for review the new drug application for its liver disease treatment, linerixibat.

Two common anti-allergy medications can leave you feeling scratchier than ever. The Food and Drug Administration is warning ...

A diet trial becomes reasonable when pruritus is persistent and nonseasonal or when standard atopy treatments fail over ...

Rilzabrutinib is a promising treatment option for patients with chronic spontaneous urticaria who are refractory to antihistamines.

“Reported cases were rare but sometimes serious, with patients experiencing widespread, severe itching that required medical ...

Panelists discuss how ruxolitinib provides comprehensive benefits for polycythemia vera patients beyond count control, highlighting its remarkable ability to rapidly alleviate severe pruritus (often ...

The US FDA issued a warning on Saturday that some popular allergy medications could cause a rare but severe itching side ...

Spring allergy season is in full swing, but the FDA has issued a warning about a rare but serious “severe itching” side effect from popular allergy medications that has affected ...